Gene-sequencing machine maker Illumina Inc has filed an appeal against an order from the U.S. Federal Trade Commission (FTC) that demands it divest cancer diagnostic test maker Grail Inc due to competition concerns.
Illumina spun off Grail in 2016 but retained a 12% stake. It reacquired Grail in 2021 despite opposition from European and U.S. regulators.Sources: Company statements, Reuters reportsOur Standards:.
Illumina spun off Grail in 2016 but retained a 12% stake. It reacquired Grail in 2021 despite opposition from European and U.S. regulators.Sources: Company statements, Reuters reportsOur Standards:Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Illumina CEO resigns following push by activist investor Carl Icahn to remove himResignation follows shareholder discontent around Illumina's acquisition of cancer diagnostic startup Grail
Read more »
Illumina announces CEO transition plan as Francis deSouza resignsIllumina announced its board of directors has accepted the resignation of CEO Francis deSouza Sunday.
Read more »
Illumina CEO Francis DeSouza resigns after battle with IcahnIllumina Chief Executive Officer Francis DeSouza stepped down on Sunday, the gene-sequencing machine maker said in a statement, ending a battle with activist investor Carl Icahn in which the company's chairman left the company earlier this year.
Read more »
Marvel To Launch Avengers Inc, From Al Ewing & Leonard KirkWe've had a Batman Inc. We've had a Joker Inc. Now, we have Avengers, Inc. But looking a bit more like the British TV show...
Read more »
Thanks to this North Texas company, It's payday for student athletes - CEO SpotlightBrent Chapman, CEO of myNILpay, Inc. joins David Johnson on this episode of CEO Spotlight.
Read more »